GOODMAN COREY S 4

Accession 0001193125-26-018039

CIK 0001810182other

View on SEC.gov Company Profile

Filed

Jan 20, 7:00 PM ET

Accepted

Jan 21, 4:30 PM ET

Size

5.1 KB

Accession

0001193125-26-018039

Research Summary

AI-generated summary of this filing

Updated Jan 21, 2026

ALX Oncology (ALXO) 10% Owner Corey S. Goodman Receives Award of 40,400 Shares

What Happened
Corey S. Goodman, a reported 10% owner of ALX Oncology Holdings, received a grant (derivative award) for 40,400 shares on 2026-01-20. The filing reports $0.00 paid at grant (typical for option or RSU awards), so no cash was exchanged. This is an acquisition-type award (code A), not an open-market purchase or sale.

Key Details

Transaction date: 2026-01-20; filing date: 2026-01-21 (filed within typical Form 4 timing).
Transaction type: Award/Grant of derivative securities (Form lists as A). Price per share shown as $0.00; total cash value reported $0.
Vesting: Footnote states the shares subject to the option vest in 12 equal monthly installments beginning February 20, 2026.
Shares owned after transaction: not specified in the filing.
Insider status: Goodman is a 10% owner—major insider; this appears to be a compensation-related award rather than a market purchase or sale.

Context: This was a grant of derivative securities (an option award) that vests over a year, so the shares are not immediately transferable. Such awards commonly reflect compensation or retention incentives and do not by themselves indicate immediate buying or selling activity.